Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Urology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Bladder Disorders Clinical Trials

A listing of Bladder Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (497) clinical trials

Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease. It is caused by excess fat in the liver that leads to inflammation and tissue injury. People with type 2 diabetes, obesity, high cholesterol, insulin resistance, and high blood pressure may have NASH. ACRC Trials is conducting a research ...

Phase

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Study Evaluating the Safety and Efficacy of Obeticholic Acid (study medication) in Subjects with Nonalcoholic Steatohepatitis (NASH).

Phase

A Randomized, Double-Blind, Parallel-Group Dose-Ranging Study to Evaluate the Safety and Efficacy of NI-03 (Study Medication) compared to Placebo in Subjects with Chronic Pancreatitis.

Phase N/A

A research study is evaluating an FDA-approved medication for overactive bladder (OAB) in older adults.

Phase N/A

A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder (OAB). This is for patients starting a new course of treatment for OAB, which may be first course of any treatment for OAB, restart or switch from one drug to another.

Phase N/A

To study the investigational drug, obeticholic acid (also known as OCA), and its effect on NASH and to find out how safe and effective OCA may be in delaying specific medical conditions or health related issues that can occur in patients with NASH and evidence of liver fibrosis. Patients will ...

Phase

Are you or someone you know suffering from the symptoms of an overactive bladder? We are conducting a research study to evaluate the effect of 2 doses of a study medication for overactive bladder.

Phase N/A

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder

Phase

Is Overactive Bladder running your life? Qualified participants must: Be at least 18 years old Have experience OAB symptoms, such as strong, sudden urge to urinate or urinate frequently for at least 6 months Qualified participants will receive: Investigational study drug or placebo Study related care at no cost Compensation ...

Phase N/A